Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Statistics

Total Valuation

MRKR has a market cap or net worth of $13.17 million. The enterprise value is -$6.66 million.

Market Cap	13.17M
Enterprise Value	-6.66M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

MRKR has 10.71 million shares outstanding. The number of shares has increased by 1.94% in one year.

Current Share Class	10.71M
Shares Outstanding	10.71M
Shares Change (YoY)	+1.94%
Shares Change (QoQ)	+2.85%
Owned by Insiders (%)	10.16%
Owned by Institutions (%)	12.89%
Float	6.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.59
Forward PS	6.14
PB Ratio	0.68
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.36

Current Ratio	6.36
Quick Ratio	6.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -65.81% and return on invested capital (ROIC) is -42.62%.

Return on Equity (ROE)	-65.81%
Return on Assets (ROA)	-35.50%
Return on Invested Capital (ROIC)	-42.62%
Return on Capital Employed (ROCE)	-59.91%
Revenue Per Employee	$1.32M
Profits Per Employee	-$2.15M
Employee Count	5
Asset Turnover	0.34
Inventory Turnover	n/a

Taxes

In the past 12 months, MRKR has paid $49,953 in taxes.

Income Tax	49,953
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.08% in the last 52 weeks. The beta is 1.54, so MRKR's price volatility has been higher than the market average.

Beta (5Y)	1.54
52-Week Price Change	-72.08%
50-Day Moving Average	1.33
200-Day Moving Average	2.93
Relative Strength Index (RSI)	47.34
Average Volume (20 Days)	54,256

Short Selling Information

The latest short interest is 400,020, so 3.74% of the outstanding shares have been sold short.

Short Interest	400,020
Short Previous Month	372,541
Short % of Shares Out	3.74%
Short % of Float	6.13%
Short Ratio (days to cover)	1.70

Income Statement

In the last 12 months, MRKR had revenue of $6.59 million and -$10.73 million in losses. Loss per share was -$1.19.

Revenue	6.59M
Gross Profit	-6.88M
Operating Income	-11.12M
Pretax Income	-5.66M
Net Income	-10.73M
EBITDA	n/a
EBIT	-11.12M
Loss Per Share	-$1.19

Balance Sheet

The company has $19.19 million in cash and n/a in debt, giving a net cash position of $19.19 million or $1.79 per share.

Cash & Cash Equivalents	19.19M
Total Debt	n/a
Net Cash	19.19M
Net Cash Per Share	$1.79
Equity (Book Value)	18.56M
Book Value Per Share	1.73
Working Capital	18.56M

Cash Flow

Operating Cash Flow	-10.91M
Capital Expenditures	n/a
Free Cash Flow	-10.91M
FCF Per Share	-$1.02

Margins

Gross margin is -104.33%, with operating and profit margins of -168.69% and -162.82%.

Gross Margin	-104.33%
Operating Margin	-168.69%
Pretax Margin	-162.06%
Profit Margin	-162.82%
EBITDA Margin	n/a
EBIT Margin	-168.69%
FCF Margin	n/a

Dividends & Yields

MRKR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.94%
Shareholder Yield	-1.94%
Earnings Yield	-85.65%
FCF Yield	-87.08%

Analyst Forecast

The average price target for MRKR is $13.17, which is 970.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.17
Price Target Difference	970.73%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	105.98%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 27, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 27, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

MRKR has an Altman Z-Score of -22.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.54
Piotroski F-Score	3